XML 37 R20.htm IDEA: XBRL DOCUMENT
v3.21.2

Earnings Per Share | 9 Months Ended
--- | ---
Sep. 30, 2021
Earnings Per Share [Abstract] |
Earnings Per Share | (14) Earnings Per Share For the three months ended September 30, 2021 and 2020, basic and diluted net income per share are calculated as follows:
|  | Three Months Ended September 30, |
|  | 2021 |  |  | 2020 |
Basic income (loss) per share |  |  |  |  |  |
Net income (loss) for the period - numerator |  | $ | 1,542,576 |  |  | $ | (520,974 | )
Weighted average common stock outstanding - denominator |  |  | 54,196,300 |  |  |  | 25,816,354 |
Net income (loss) per share |  | $ | 0.03 |  |  | $ | (0.02 | )
Diluted income per share |  |  |  |  |  |  |  |
Net income for the period- numerator |  | $ | 1,542,576 |  |  | $ | (520,974 | )
Weighted average common stock outstanding - denominator |  |  | 54,196,300 |  |  |  | 25,816,354 |
Effect of dilution |  |  | - |  |  |  | - |
Weighted average common stock outstanding - denominator |  |  | 54,196,300 |  |  |  | 25,816,354 |
Diluted income (loss) per share |  | $ | 0.03 |  |  | $ | (0.02 | )
For the nine months ended September 30, 2021 and 2020, basic and diluted net income per share are calculated as follows:
|  | Nine Months Ended September 30, |
|  | 2021 |  |  | 2020 |
Basic loss per share |  |  |  |  |  |
Net loss for the period - numerator |  | $ | (3,249,528 | ) |  | $ | (3,937,292 | )
Weighted average common stock outstanding - denominator |  |  | 54,196,300 |  |  |  | 25,816,354 |
Net loss per share |  | $ | (0.06 | ) |  | $ | (0.15 | )
Diluted loss per share |  |  |  |  |  |  |  |
Net loss for the period - numerator |  | $ | (3,249,528 | ) |  | $ | (3,937,292 | )
Weighted average common stock outstanding - denominator |  |  | 54,196,300 |  |  |  | 25,816,354 |
Effect of dilution |  |  | - |  |  |  | - |
Weighted average common stock outstanding - denominator |  |  | 54,196,300 |  |  |  | 25,816,354 |
Diluted loss per share |  | $ | (0.06 | ) |  | $ | (0.15 | )
For the three and nine months ended September 30, 2021 and 2020 there were no securities with dilutive effect issued and outstanding.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -URI http://asc.fasb.org/topic&trid=2144383 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration